P1104: A PHASE 1 STUDY EVALUATING SAFETY AND EFFICACY OF PARSACLISIB IN COMBINATION WITH BENDAMUSTINE + OBINUTUZUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA (CI...

por Hamadani, M., Coleman, M., Boccia, R., Duras, J., Hutchings, M., Zinzani, P. L., Cordoba, R., Oreiro, M. B., Williams, V., Stouffs, M., Langmuir, P., Sancho, J.-M.
Publicado 2022

A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy

por Glaspy, J, Jadeja, J Singh, Justice, G, Kessler, J, Richards, D, Schwartzberg, L, Rigas, J, Kuter, D, Harmon, D, Prow, D, Demetri, G, Gordon, D, Arseneau, J, Saven, A, Hynes, H, Boccia, R, O'Byrne, J, Colowick, A B
Publicado 2001

Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trial

por Weiss, J M, Csoszi, T, Maglakelidze, M, Hoyer, R J, Beck, J T, Domine Gomez, M, Lowczak, A, Aljumaily, R, Rocha Lima, C M, Boccia, R V, Hanna, W, Nikolinakos, P, Chiu, V K, Owonikoko, T K, Schuster, S R, Hussein, M A, Richards, D A, Sawrycki, P, Bulat, I, Hamm, J T, Hart, L L, Adler, S, Antal, J M, Lai, A Y, Sorrentino, J A, Yang, Z, Malik, R K, Morris, S R, Roberts, P J, Dragnev, K H
Publicado 2019